Geoffrey Henson

5.2k citations

31 papers · 4.1k indexed · 2 hit papers · h-index 23

Immunology top 1%
Oncology top 1%
Virology top 0.5%
Molecular Biology top 10%
Infectious Diseases top 2%

Co-authors: Erik De Clercq Dominique Schols Gary Bridger José A. Esté Sofie Struyf Jo Van Damme R. T. MacFarland Charles Flexner
Topics: HIV Research and Treatment (16 papers)Immune Cell Function and Interaction (12 papers)HIV/AIDS drug development and treatment (9 papers)
Cited by: Virology Immunology Oncology
Journals: Nature Nature Medicine The Journal of Experimental Medicine
Partner nations: Belgium United States United Kingdom

In The Last Decade

Geoffrey Henson

30 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor

1998 634 citations Dominique Schols, Steven Lin et al. Nature Medicine profile →
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist

2003 561 citations W. Conrad Liles, Hal E. Broxmeyer et al. Blood profile →

Peers

Countries citing papers authored by Geoffrey Henson

Since Specialization

Citations

This map shows the geographic impact of Geoffrey Henson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Henson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Henson more than expected).

Fields of papers citing papers by Geoffrey Henson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey Henson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Henson. The network helps show where Geoffrey Henson may publish in the future.

Co-authorship network of co-authors of Geoffrey Henson

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey Henson. A scholar is included among the top collaborators of Geoffrey Henson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey Henson. Geoffrey Henson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dual pro-drugs of 2′-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus 2011 ·Bioorganic & Medicinal Chemistry Letters ·Christopher McGuigan,Karolina Madela,(unknown),Arnaud Gilles,Srinivas K. Battina,(unknown),C. Srinivas Rao,John Vernachio,Jeff Hutchins,Andrea Hall,Alexander A. Kolykhalov,Geoffrey Henson,Stanley D. Chamberlain	14
2	Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus 2010 ·Bioorganic & Medicinal Chemistry Letters ·Christopher McGuigan,Karolina Madela,(unknown),Arnaud Gilles,Andrea Brancale,Nicola Zonta,Stanley D. Chamberlain,John Vernachio,Jeff Hutchins,Andrea Hall,Brenda Ames,Elena Gorovits,(unknown),Alexander A. Kolykhalov,Jin Wang,Jerry Muhammad,Joseph M. Patti,Geoffrey Henson	73
3	2′-Fluorosugar analogues of the highly potent anti-varicella-zoster virus bicyclic nucleoside analogue (BCNA) Cf 1743 2009 ·Bioorganic & Medicinal Chemistry Letters ·Christopher McGuigan,Marco Derudas,Maurizio Quintiliani,Graciela Andreï,Robert Snoeck,Geoffrey Henson,Jan Balzarini	6
4	Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus 2007 ·Journal of Antimicrobial Chemotherapy ·Christopher McGuigan,Ranjith Pathirana,Marco Migliore,(unknown),(unknown),Arwyn T. Jones,(unknown),Marı́a-José Camarasa,Sonsoles Velázquez,Geoffrey Henson,Erik Verbeken,(unknown),Lieve Naesens,Robert Snoeck,Graciela Andreï,Jan Balzarini	62
5	Synthesis and Antiviral Activity of the Carbocyclic Analogue of the Highly Potent and Selective Anti-VZV Bicyclo Furano Pyrimidines 2007 ·Journal of Medicinal Chemistry ·Marco Migliore,Nicola Zonta,Christopher McGuigan,Geoffrey Henson,Graciela Andreï,Robert Snoeck,Jan Balzarini	17
6	Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 Antagonist 2004 ·PubMed ·Kai Hübel,W. Conrad Liles,Hal E. Broxmeyer,Elin Rodger,Brent L. Wood,Scott Cooper,Giao Hangoc,Ron MacFarland,Gary Bridger,Geoffrey Henson,Gary Calandra,David C. Dale	77
7	Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Craig W. Hendrix,Ann C. Collier,Michael M. Lederman,Dominique Schols,Richard B. Pollard,Stephen Brown,J. Brooks Jackson,Robert W. Coombs,Marshall J. Glesby,Charles Flexner,Gary Bridger,Karin Badel,R. T. MacFarland,Geoffrey Henson,Gary Calandra	284
8	Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonistbreakdown → 2003 ·Blood ·W. Conrad Liles,Hal E. Broxmeyer,Elin Rodger,Brent L. Wood,Kai Hübel,Scott Cooper,Giao Hangoc,Gary Bridger,Geoffrey Henson,Gary Calandra,David C. Dale	561
9	AMD3100, a Potent and Specific Antagonist of the Stromal Cell-Derived Factor-1 Chemokine Receptor CXCR4, Inhibits Autoimmune Joint Inflammation in IFN-γ Receptor-Deficient Mice 2001 ·The Journal of Immunology ·Patrick Matthys,Sigrid Hatse,Kurt Vermeire,Anja Wuyts,Gary Bridger,Geoffrey Henson,Erik De Clercq,Alfons Billiau,Dominique Schols	215
10	Mutation of Asp¹⁷¹and Asp²⁶²of the Chemokine Receptor CXCR4 Impairs Its Coreceptor Function for Human Immunodeficiency Virus-1 Entry and Abrogates the Antagonistic Activity of AMD3100 2001 ·Molecular Pharmacology ·Sigrid Hatse,Katrien Princen,Lars‐Ole Gerlach,Gary Bridger,Geoffrey Henson,Erik De Clercq,Thue W. Schwartz,Dominique Schols	99
11	Activity of Different Bicyclam Derivatives against Human Immunodeficiency Virus Depends on Their Interaction with the CXCR4 Chemokine Receptor 1999 ·Molecular Pharmacology ·José A. Esté,Cecilia Cabrera,Erik De Clercq,Sofie Struyf,Jo Van Damme,Gary Bridger,Renato T. Skerlj,Michael J. Abrams,Geoffrey Henson,Arantxa Gutiérrez,Bonaventura Clotet,Dominique Schols	79
12	Activity of Different Bicyclam Derivatives against Human Immunodeficiency Virus Depends on Their Interaction with the CXCR4 Chemokine Receptor 1999 ·Molecular Pharmacology ·José A. Esté,Cecilia Cabrera,Erik De Clercq,Sofie Struyf,Jo Van Damme,Gary Bridger,Renato T. Skerlj,Michael J. Abrams,Geoffrey Henson,Arantxa Gutiérrez,Bonaventura Clotet,Dominique Schols	3
13	AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptorbreakdown → 1998 ·Nature Medicine ·(unknown),Dominique Schols,Steven Lin,José A. Esté,Kirsten Nagashima,Paul J. Maddon,Graham P. Allaway,Thomas P. Sakmar,Geoffrey Henson,Erik De Clercq,John P. Moore	634
14	Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor Fusin/CXCR-4 1997 ·Antiviral Research ·Dominique Schols,José A. Esté,Geoffrey Henson,Erik De Clercq	190
15	Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4 1997 ·The Journal of Experimental Medicine ·Dominique Schols,Sofie Struyf,Jo Van Damme,José A. Esté,Geoffrey Henson,Erik De Clercq	493
16	Pharmacokinetics of Polyoxometalates after Multiple‐dose Administration in Rats 1996 ·Pharmacy and Pharmacology Communications ·Lan Ni,Geoffrey Henson,Marilyn C. Darkes,Gerald E. Bossard,F. Douglas Boudinot	4
17	The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding 1996 ·Antiviral Research ·K De Vreese,D. Reymen,Philip Griffin,Alexander Steinkasserer,Gudrun Werner,Gary Bridger,José A. Esté,William James,Geoffrey Henson,Jan Desmyter,Jozef Anné,Erik De Clercq	50
18	A Comparison of Cleavable and Noncleavable Hydrazinopyridine Linkers for the^99mTc Labeling of Fab‘ Monoclonal Antibody Fragments 1996 ·Bioconjugate Chemistry ·Gary Bridger,Michael J. Abrams,Sreenivasan Padmanabhan,Forrest E. Gaul,Scott K. Larsen,Geoffrey Henson,David A. Schwartz,Clifford Longley,Charlotte Burton,(unknown)	22
19	Antiviral activity of the bicyclam derivative JM3100 against drug-resistant strains of human immunodeficiency virus type 1 1996 ·Antiviral Research ·José A. Esté,K De Vreese,Myriam Witvrouw,Jean‐Claude Schmit,Anne–Mieke Vandamme,Jozef Anné,Jan Desmyter,Geoffrey Henson,Gary Bridger,Erik De Clercq	30
20	Synthesis and Structure-Activity Relationships of Phenylenebis(methylene)-Linked Bis-Tetraazamacrocycles That Inhibit HIV Replication. Effects of Macrocyclic Ring Size and Substituents on the Aromatic Linker 1995 ·Journal of Medicinal Chemistry ·Gary Bridger,Renato T. Skerlj,David A. Thornton,Sreenivasan Padmanabhan,Stephen A. Martellucci,Geoffrey Henson,Michael J. Abrams,Naohiko Yamamoto,K De Vreese	193

About Geoffrey Henson

Geoffrey Henson is a scholar working on Virology, Immunology and Infectious Diseases, having authored 31 papers that have together received 4.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (16 papers), Immune Cell Function and Interaction (12 papers) and HIV/AIDS drug development and treatment (9 papers). The work is most often cited by research in Virology (1.5k citations), Immunology (2.0k citations) and Oncology (1.7k citations). Geoffrey Henson has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Erik De Clercq, Dominique Schols, Gary Bridger, José A. Esté, Sofie Struyf, Jo Van Damme, R. T. MacFarland, Charles Flexner, Craig W. Hendrix and Thomas P. Sakmar. Their work appears in journals such as Nature, Nature Medicine and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact